Khan Mohammad Imran - Search Results

Year	Number of Results
2004	2
2005	5
2006	4
2007	1
2008	1
2011	2
2012	1
2013	3
2014	3
2015	2
2016	3
2017	8
2018	9
2019	13
2020	13
2021	20
2022	23
2023	24
2024	9

1

Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse pancreatic cancer model.

Imran KM, Brock RM, Beitel-White N, Powar M, Orr K, Aycock KN, Alinezhadbalalami N, Salameh ZS, Eversole P, Tintera B, Markov Madanick J, Hendricks-Wenger A, Coutermarsh-Ott S, Davalos RV, Allen IC. Imran KM, et al. Front Immunol. 2024 Apr 22;15:1352821. doi: 10.3389/fimmu.2024.1352821. eCollection 2024. Front Immunol. 2024. PMID: 38711517 Free PMC article.

2

Editorial: Novel theranostic agents for precision therapeutics.

Karim S, Siddiqui NA, Khan MI, Wahajuddin M, Syed S. Karim S, et al. Among authors: khan mi. Front Pharmacol. 2024 Apr 17;15:1407366. doi: 10.3389/fphar.2024.1407366. eCollection 2024. Front Pharmacol. 2024. PMID: 38694918 Free PMC article. No abstract available.

3

Avocado-derived extracellular vesicles loaded with ginkgetin and berberine prevent inflammation and macrophage foam cell formation.

Sharma S, Mahanty M, Rahaman SG, Mukherjee P, Dutta B, Khan MI, Sankaran KR, He X, Kesavalu L, Li W, Rahaman SO. Sharma S, et al. Among authors: khan mi. J Cell Mol Med. 2024 Apr;28(7):e18177. doi: 10.1111/jcmm.18177. J Cell Mol Med. 2024. PMID: 38494843 Free PMC article.

4

In silico exploration of the potential inhibitory activities of in-house and ZINC database lead compounds against alpha-glucosidase using structure-based virtual screening and molecular dynamics simulation approach.

Awan ZA, Khan HA, Jamal A, Shams S, Zheng G, Wadood A, Shahab M, Khan MI, Kalantan AA. Awan ZA, et al. Among authors: khan mi. J Biomol Struct Dyn. 2024 Jan 31:1-11. doi: 10.1080/07391102.2023.2298391. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38294714

5

Design, synthesis, molecular modeling, and biological evaluations of novel chalcone based 4-Nitroacetophenone derivatives as potent anticancer agents targeting EGFR-TKD.

Mir SA, Murmu N, Meher RK, Baitharu I, Nayak B, Khan A, Khan MI, Abdulaal WH. Mir SA, et al. Among authors: khan mi. J Biomol Struct Dyn. 2024 Jan 28:1-16. doi: 10.1080/07391102.2024.2301746. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38281944

6

Computational insights into the stereo-selectivity of catechins for the inhibition of the cancer therapeutic target EGFR kinase.

Rehan M, Ahmed F, Khan MI, Ansari HR, Shakil S, El-Araby ME, Hosawi S, Saleem M. Rehan M, et al. Among authors: khan mi. Front Pharmacol. 2024 Jan 11;14:1231671. doi: 10.3389/fphar.2023.1231671. eCollection 2023. Front Pharmacol. 2024. PMID: 38273823 Free PMC article.

7

Computational Molecular Docking and Simulation-Based Assessment of Anti-Inflammatory Properties of Nyctanthes arbor-tristis Linn Phytochemicals.

Ahmad V, Khan MI, Jamal QMS, Alzahrani FA, Albiheyri R. Ahmad V, et al. Among authors: khan mi. Pharmaceuticals (Basel). 2023 Dec 22;17(1):18. doi: 10.3390/ph17010018. Pharmaceuticals (Basel). 2023. PMID: 38256852 Free PMC article.

8

Correction: Harnessing the Electrochemical Effects of Electroporation-Based Therapies to Enhance Anti-tumor Immune Responses.

Salameh ZS, Aycock KN, Alinezhadbalalami N, Imran KM, McKillop IH, Allen IC, Davalos RV. Salameh ZS, et al. Among authors: imran km. Ann Biomed Eng. 2024 Apr;52(4):1106. doi: 10.1007/s10439-024-03444-w. Ann Biomed Eng. 2024. PMID: 38200225 Free PMC article. No abstract available.

9

Harnessing the Electrochemical Effects of Electroporation-Based Therapies to Enhance Anti-tumor Immune Responses.

Salameh ZS, Aycock KN, Alinezhadbalalami N, Imran KM, McKillop IH, Allen IC, Davalos RV. Salameh ZS, et al. Among authors: imran km. Ann Biomed Eng. 2024 Jan;52(1):48-56. doi: 10.1007/s10439-023-03403-x. Epub 2023 Nov 21. Ann Biomed Eng. 2024. PMID: 37989902 Free PMC article.

10

Green synthesis of silver nanoparticles from plant Fagonia cretica and evaluating its anti-diabetic activity through indepth in-vitro and in-vivo analysis.

Khan HA, Ghufran M, Shams S, Jamal A, Khan A, Abdullah, Awan ZA, Khan MI. Khan HA, et al. Among authors: khan mi. Front Pharmacol. 2023 Oct 23;14:1194809. doi: 10.3389/fphar.2023.1194809. eCollection 2023. Front Pharmacol. 2023. PMID: 37936909 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

126 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year